Tuttle et al. (23) illustrated that once-weekly dulaglutide delayed the decrease in estimated glomerular filtration rate (eGFR), declined hyperglycemia, and dropped urine albumin/creatinine scale when compared with insulin. The gene discussed is INS; the disease is Hyperglycemia.